Pfizer's Options: A Look at What the Big Money is Thinking
Portfolio Pulse from Benzinga Insights
Financial analysis reveals a bullish sentiment among big money traders on Pfizer (NYSE:PFE), with 66% of observed options trades being bullish. The analysis, based on 15 unusual trades, shows a preference for calls over puts, indicating expectations for Pfizer's stock to rise. The targeted price range for these options is between $20.0 and $50.0. Pfizer, a leading pharmaceutical company with annual sales nearing $50 billion, is currently experiencing a slight increase in stock price to $27.7, with an upcoming earnings release in 35 days.
March 27, 2024 | 5:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer shows a bullish sentiment among investors, with a significant portion of options trades indicating a positive outlook. The stock is currently up by 0.4% at $27.7, with an anticipated earnings release in 35 days.
The bullish sentiment is evidenced by the 66% bullish options trades and the current slight increase in stock price. The anticipation of the earnings release in 35 days may further influence the stock's performance, making this a critical period for investors.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100